Incorporating patient-specific factors, including genetic markers, metabolic profiles, and patterns of albuminuria, can facilitate earlier detection, improve prognostic accuracy and enable more precise selection of therapeutic interventions, moving clinical practice towards individualized management strategies [34,35,36,37]
Improvements in steatosis and hepatocyte ballooning scores were also observed
Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study
The zeta potential of -31.87 mV confirms strong electrostatic repulsion between particles, preventing aggregation and maintaining uniform dispersion throughout the shelf life
Proc Natl Acad Sci USA 92: 39483952
doi: 10.1111/j.1364-3703.2004.00239.x 21 DelmerD.DixonR